In 2023, the sales of analgesic medicine in Italy stood at 387.5 million Euros. The forecasted data from 2024 to 2028 shows a steady increase in sales year-on-year. By 2024, the sales are projected to reach 389.7 million Euros, a modest increase. The upward trend continues with sales expected to be 390.9 million Euros in 2025, 391.8 million Euros in 2026, 392.6 million Euros in 2027, and 393.2 million Euros in 2028.
Year-on-year variation percentages:
- From 2023 to 2024: +0.57%
- From 2024 to 2025: +0.31%
- From 2025 to 2026: +0.23%
- From 2026 to 2027: +0.20%
- From 2027 to 2028: +0.15%
Over the last two years (2023-2024), the variation was +0.57%. Over the last five years, the Compound Annual Growth Rate (CAGR) stood at +0.29%.
Future trends to watch for include the impact of demographic shifts such as aging populations, advancements in medical technology, and potential shifts in consumer preferences towards alternative pain management solutions. Additionally, regulatory policies and the economic environment will play a critical role in shaping the market dynamics.
